Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Biotricity Inc. (BTCY) had Revenue of $12.06M for the most recently reported fiscal year, ending 2024-03-31.

Quarterly Annual

Figures for fiscal year ending 2024-03-31

Income Statement Financials
Revenue	$12.06M
Net Income	$-14.93M
Cost of Goods Sold	$3.71M
Gross Profit	$8.36M
Operating Expenses	$20.89M
Operating Income	$-8.83M
Non-Operating Income/Expense	$-5.27M
Pre-Tax Income	$-14.09M
Normalized Pre-Tax Income	$-14.09M
Income after Taxes	$-14.09M
Income from Continuous Operations	$-14.09M
Consolidated Net Income/Loss	$-14.09M
Normalized Income after Taxes	$-14.09M
EBIT	$-8.83M
EBITDA	$-6.65M
Weighted-Average Shares Outstanding (Basic)	8.99M
Weighted-Average Shares Outstanding (Diluted)	8.99M
Earnings per Share (EPS) (Basic)	$-1.66
Earnings per Share (EPS) (Diluted)	$-1.66
Balance Sheet Financials
Current Assets	$4.47M
Property, Plant, and Equipment	$0.02M
Long-Term Assets	$1.47M
Total Assets	$5.94M
Current Liabilities	$22.70M
Long-Term Debt	$10.86M
Long-Term Liabilities	$14.71M
Total Liabilities	$37.41M
Common Equity	$-31.47M
Tangible Shareholders Equity	$-31.47M
Shareholders Equity	$-31.47M
Common Shares Outstanding	9.35M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-6.69M
Cash Flow from Investing Activities	--
Cash Flow from Financial Activities	$6.74M
Beginning Cash	$0.57M
End Cash	$0.79M
Increase/Decrease in Cash	$0.22M
Stock-Based Compensation	$1.14M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	$-0.02M
Fundamental Metrics & Ratios
Current Ratio	0.20
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-0.53
Debt to Equity Ratio	-0.71
Gross Margin	69.27%
Operating Margin	-73.18%
EBIT Margin	-73.18%
EBITDA Margin	-55.12%
Pre-Tax Profit Margin	-116.84%
Profit Margin	-123.75%
Free Cash Flow	$-6.69M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	2.03
Inventory Turnover	1.97
Receiveable Turnover	8.21
Days Sales in Receivables	44.44
Return on Equity	44.79%
Return on Tangible Equity	44.79%
Return on Assets	-237.17%
Return on Investments	68.39%
Book Value Per Share	$-3.36
Free Cash Flow per Share	$-0.74
Operating Cash Flow per Share	$-0.74

Data from Zacks Investment Research, Inc.